Global Transdermal (Percutaneous) Drug Delivery Systems Market Size, Share, Forecast Report, 2020-2027

The global Transdermal (Percutaneous) Drug Delivery Systems market garnered revenue around USD XX Billion in 2019 and projected to reach USD XX Billion in 2027, with at a compound annual growth rate of 4.8% throughout the estimate period from 2020 to 2027.

Transdermal drug delivery system (TDDS) delivers drugs through the skin to systemic circulation at a predetermined rate and maintain the effective concentrations clinically over an extended period. TDDS also called as patches are dosage forms that deliver a therapeutically effective amount of drug via the patients' skin. Worldwide growing geriatric population along with rising in the prevalence of chronic diseases is the leading factor driving the market growth. In addition, rapid technological advancements in transdermal drug delivery systems and increasing adoption of third-generation delivery systems are expected to augment the market growth during the forecast period. The geriatric population is more prone to develop Q fever.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Transdermal (Percutaneous) Drug Delivery Systems market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Transdermal (Percutaneous) Drug Delivery Systems market growth.

The global Transdermal (Percutaneous) Drug Delivery Systems market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

• Mylan N.V.

• Hisamitsu Pharmaceutical Co., Inc.

• Novartis International AG

• Boehringer Ingelheim International GmbH

• GlaxoSmithKline PLC

• Johnson & Johnson Services, Inc.

• Endo Pharmaceuticals Inc.

• UCB S.A.

• Pfizer Inc.

• Allergan plc

• Actelion Pharmaceuticals Ltd

• Noven Pharmaceuticals, Inc.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Transdermal (Percutaneous) Drug Delivery Systems Market, by Product

• Transdermal Patches

o Drug-In-Adhesive Patches

o Matrix Patches

o Reservoir Membrane Patches

o Microneedle Patches

• Transdermal Semisolids

o Gels

o Ointments

o Sprays

Global Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology

• Electric Current

• Iontophoresis

• Electroporation

• Ultrasound

• Microporation

• Thermal

• Others

Global Transdermal (Percutaneous) Drug Delivery Systems Market, by Application

• Pain Management

• Cardiovascular Diseases

• Hormone Replacement Therapy

• Central Nervous System Disorders

• Smoking Cessation

• Contraception

• Others

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America

 U.S.

 Canada

• Europe

 Germany

 U.K.

 Italy

 France

 Rest of EU

• Asia Pacific

 China

 India

 Japan

 Southeast Asia

 Rest of APAC

• Central & South America

 Brazil

 Argentina

 Rest of Central & South America

• Middle East and Africa


 Saudi Arabia

 Rest of MEA